Related Experiment Video
Updated: Oct 4, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MicroRNA-221 promotes tumor progression by targeting HHIP in human glioblastoma
Liang Chang1, Lisheng Yin1, Dongzhi Zhang1
1Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China.
Background:
MicroRNAs are found to be aberrantly expressed in multiple cancers, including glioblastoma (GBM), and microRNA-221 (miR-221) has been verified as an oncogene in various human cancers. Nevertheless, the role of miR-221 in GBM is unclear. This study aimed to investigate the miR-221 expression level in GBM and to evaluate its function and underlying mechanisms.
Methods:
Western blotting and qPCR were used to determine the expression of human hedgehog-interacting protein (HHIP) and miR-221 levels. MiR-221-inhibited cell models were constructed, and siRNA was used for HHIP silencing. Cell proliferation was analyzed by MTT and colony formation assays and a subcutaneous xenograft model. Cell migration and invasion was analyzed by wound healing and Transwell invasion assays. A dual luciferase reporter assay system was used to clarify the relationship between miR-221 and HHIP.
Results:
The results of this study revealed that miR-221 expression was upregulated in GBM tissues and A172, U251, as well as T98G cells, as detected by real-time PCR analysis. MTT, Transwell, and colony formation assays revealed that miR-221 knockdown could suppress GBM cells from proliferating, migrating, and invading in vitro. Moreover, animal experiments showed that tumor growth in vivo was inhibited when miR-221 expression decreased. Furthermore, HHIP was predicted and verified to be a target of miR-221 by bioinformatics analysis, and luciferase and western blot assays. In addition, HHIP silencing rescued the suppressive effect of a miR-221 inhibitor on the proliferation, migration, and invasion of GBM cells.
Conclusions:
Our results indicated that miR-221 is upregulated in GBM and enhances tumor progression by targeting HHIP, which suggests this may be a potential therapeutic target for GBM.
Insights
MicroRNA-221 (miR-221) is upregulated in glioblastoma (GBM), promoting tumor growth and spread. Inhibiting miR-221 and its target, HHIP, suppressed GBM progression, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are implicated in various cancers, with aberrant expression observed in glioblastoma (GBM).
- MicroRNA-221 (miR-221) is recognized as an oncogene in several cancers, but its specific role in GBM remains largely unelucidated.
- This study investigates the expression and functional significance of miR-221 in GBM.
Purpose of the Study:
- To determine the expression level of miR-221 in glioblastoma.
- To evaluate the functional role of miR-221 in GBM cell proliferation, migration, and invasion.
- To elucidate the underlying molecular mechanisms, including identifying miR-221 targets in GBM.
Main Methods:
- Quantitative real-time PCR (qPCR) and Western blotting were employed to assess miR-221 and human hedgehog-interacting protein (HHIP) expression.
- Cellular assays including MTT, colony formation, wound healing, and Transwell invasion assays were performed on miR-221-inhibited GBM models.
- In vivo studies utilized a subcutaneous xenograft model to evaluate tumor growth. Bioinformatics, dual-luciferase reporter assays, and Western blotting confirmed the interaction between miR-221 and HHIP.
Main Results:
- Real-time PCR confirmed elevated miR-221 expression in GBM tissues and cell lines (A172, U251, T98G).
- Downregulation of miR-221 significantly inhibited GBM cell proliferation, migration, and invasion in vitro, and suppressed tumor growth in vivo.
- Human hedgehog-interacting protein (HHIP) was identified and validated as a direct target of miR-221. Silencing HHIP expression abrogated the inhibitory effects of miR-221 knockdown on GBM progression.
Conclusions:
- MicroRNA-221 is upregulated in glioblastoma and acts as an oncogene by promoting tumor progression.
- The oncogenic function of miR-221 in GBM is mediated through the suppression of its target, HHIP.
- Targeting the miR-221/HHIP axis presents a promising therapeutic strategy for glioblastoma treatment.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Experimental RNAi
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

